CYP2A6 and lung adenocarcinoma: Lung adenocarcinoma patients with the CYP2A6 gene retain-type had significantly (p = 0.0099) better OS compared with squamous cell carcinoma patients with the CYP2A6 gene retain-type (Fig. 1).